Tim Hugo Maria Jonckers
77Patents
17h-index
61Co-inventors
83Inventor score
Filing activity: Nov 28, 2006 → Oct 19, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8552021B2 | Phosphoramidate derivatives of nucleosides | Human Necessities | 44 | Active |
| US8916575B2 | Quinazoline derivatives for the treatment of viral infections and further diseases | Chemistry; Metallurgy | 39 | Active |
| US8481510B2 | Uracyl spirooxetane nucleosides | Chemistry; Metallurgy | 31 | Active |
| US9422250B2 | Pyrimidine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 29 | Active |
| US8399429B2 | Uracyl cyclopropyl nucleotides | Human Necessities | 29 | Active |
| US9499549B2 | Pyrrolo[3,2-]pyrimidine derivatives for the treatment of viral infections and other diseases | Chemistry; Metallurgy | 29 | Active |
| US9598378B2 | 2-aminopyrimidine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 29 | Active |
| US9663474B2 | Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections | Chemistry; Metallurgy | 27 | Active |
| US9012428B2 | Uracyl spirooxetane nucleoside phosphoramidates | Human Necessities | 27 | Active |
| US9133192B2 | Piperidino-pyrimidine derivatives for the treatment of viral infections | Human Necessities | 27 | Active |
| US9284304B2 | Substituted pyrimidines as toll-like receptor modulators | Chemistry; Metallurgy | 27 | Active |
| US9365571B2 | Piperidino-pyrimidine derivatives for the treatment of viral infections | Human Necessities | 26 | Active |
| US9422323B2 | Uracyl spirooxetane nucleosides | Chemistry; Metallurgy | 25 | Active |
| US8933052B2 | Uracyl spirooxetane nucleosides | Chemistry; Metallurgy | 24 | Active |
| US8431588B2 | Cyclopropyl polymerase inhibitors | Human Necessities | 23 | Active |
| US9944598B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US10029984B2 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 20 | Active |
| US9617289B2 | RSV antiviral compounds | Chemistry; Metallurgy | 14 | Active |
| US10206902B2 | Mono- or di-substituted indoles as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 14 | Active |
| US8921560B2 | Indoles as respiratory syncytial virus antiviral agents | Chemistry; Metallurgy | 10 | Active |
| US8846672B2 | Imidazopyridines as respiratory syncytial virus antiviral agents | Chemistry; Metallurgy | 9 | Active |
| US8927720B2 | Azabenzimidazoles as respiratory syncytial virus antiviral agents | Chemistry; Metallurgy | 8 | Active |
| US9051317B2 | Azaindoles as respiratory syncytial virus antiviral agents | Chemistry; Metallurgy | 6 | Active |
| US9339494B2 | Azaindoles as respiratory syncytial virus antiviral agents | Chemistry; Metallurgy | 6 | Active |
| US9006209B2 | Uracyl spirooxetane nucleoside phosphoramidates | Chemistry; Metallurgy | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.